US drug firms eye ibogaine amid concerns over Gabonese supply

US pharmaceutical companies are increasingly interested in ibogaine, a compound derived from the iboga plant traditionally used in Gabonese spiritual ceremonies. This interest is driven by preliminary research suggesting ibogaine's potential in treating addiction and mental health disorders, according to a report by the Daily Mail.

Ibogaine's therapeutic potential

Ibogaine, extracted from the iboga plant's root bark, is being investigated for its potential to alleviate withdrawal symptoms and reduce cravings in individuals with substance dependencies. Some studies have also explored its effects on depression, anxiety, and PTSD. A 2024 study by Stanford Medicine reported significant symptom reductions in veterans with traumatic brain injuries following ibogaine treatment, though researchers emphasize the need for larger, controlled trials.

Conservation concerns in Gabon

The surge in interest from Western pharmaceutical companies has raised alarms in Gabon, where iboga is harvested. Yann Guignon, president of the conservation group Blessings of the Forest, expressed concerns about overharvesting, noting that up to 90% of wild iboga has been poached over the past 50 years. The increasing demand from abroad threatens the plant's availability for traditional use in Gabonese Bwiti ceremonies.

Comparisons to ayahuasca

The situation mirrors the global rise of ayahuasca, another psychoactive plant with Indigenous roots. Like ayahuasca, ibogaine has attracted celebrity attention, with figures like Mike Tyson and Jordan Belfort publicly discussing their experiences. However, ibogaine's use is not without risks, as it can cause severe heart issues and is illegal or heavily regulated in many countries.

Why it matters

The growing pharmaceutical interest in ibogaine highlights a potential new avenue for addiction treatment but also underscores the need for sustainable practices that respect and preserve traditional uses and the natural environment. Gabon is exploring ways to protect both the iboga species and the cultural heritage associated with it.

The balance between medical innovation and conservation remains a critical issue as ibogaine's popularity grows.